# Revolutionary Blood Factory: A Stem Cell Breakthrough! Newsy: Serious Science Stories Published: 2025-11-20T16:01:00.500Z Source: https://newsyai.com/edition/a746364d-3fdd-4781-9cbe-2fe3684c45ef Archive: https://newsyai.com/newsy/be8c0f0f-69bc-4ce8-9617-1c38b4b251a3.md --- # Serious Science Stories — November 20, 2025 Fresh breakthroughs from roughly the last 24 hours. What happened, why it matters, and quick links to dive deeper. 1) Tiny “blood factory” grown from human cells - What’s new: Scientists built a palm‑sized, fully human bone‑marrow model that actually makes blood for weeks. It recreates the hard‑to‑copy “endosteal niche” (bone, blood vessels, nerves, immune cells) using stem‑cell‑derived tissues. - Why it matters: This lifelike testbed could speed drug discovery for leukemias and other blood disorders, reduce animal use, and one day let doctors “trial” therapies on a patient’s own marrow model. - Read more: University of Basel summary + paper in Cell Stem Cell. [ScienceDaily](https://www.sciencedaily.com/releases/2025/11/251120092103.htm) (with journal DOI) ([sciencedaily.com](https://www.sciencedaily.com/releases/2025/11/251120092103.htm)) 2) Light’s “hidden” magnetic side steps into the spotlight - What’s new: A team shows the magnetic field of light directly contributes to the classic Faraday effect (how light’s polarization twists in a magnetic field) — overturning a 180‑year assumption that only light’s electric field mattered. - Why it matters: Rethinking this basic interaction could sharpen optical isolators, data‑storage parts, and spin‑based photonics used in next‑gen sensors and quantum devices. - Read more: Hebrew University release + Scientific Reports paper. [ScienceDaily](https://www.sciencedaily.com/releases/2025/11/251120091945.htm) ([sciencedaily.com](https://www.sciencedaily.com/releases/2025/11/251120091945.htm)) 3) Compact fusion device reaches gigapascal plasma pressures - What’s new: Zap Energy’s latest Z‑pinch (FuZE‑3) hit electron pressures of ~830 MPa (about 1.6 GPa total plasma pressure) — extreme conditions sustained for microseconds and measured by Thomson scattering. - Why it matters: High pressure combines heat and density, the combo fusion needs. It’s not “net‑energy” yet, but it’s a concrete step for a small, relatively simple machine design. - Read more: Company report shared at the APS Plasma meeting. [ScienceDaily](https://www.sciencedaily.com/releases/2025/11/251120002836.htm) ([sciencedaily.com](https://www.sciencedaily.com/releases/2025/11/251120002836.htm)) 4) Pulling drinking water from thin air — in minutes, not hours - What’s new: MIT engineers use ultrasound to “shake” water loose from air‑harvesting sponges, recovering moisture in minutes instead of the usual long solar‑heating cycle. A small solar cell can power the device and automate repeated cycles. - Why it matters: Faster, gentler recovery could make off‑grid, point‑of‑use water systems practical in arid places — think window‑sized units that fill a bottle several times a day. - Read more: MIT summary + Nature Communications paper. [ScienceDaily](https://www.sciencedaily.com/releases/2025/11/251120002834.htm) ([sciencedaily.com](https://www.sciencedaily.com/releases/2025/11/251120002834.htm)) 5) The fossil‑fuel network is closer to home than you think - What’s new: First national map of “mid‑supply‑chain” infrastructure (storage, transport, refining) finds 46.6 million people in the contiguous U.S. live within ~1 mile of at least one fossil‑fuel site — not just wells or power plants. - Why it matters: These largely overlooked facilities can emit harmful compounds; knowing who lives near them helps target monitoring, health studies, and smarter zoning. - Read more: Boston University analysis in Environmental Research Letters. [ScienceDaily](https://www.sciencedaily.com/releases/2025/11/251118212039.htm) ([sciencedaily.com](https://www.sciencedaily.com/releases/2025/11/251118212039.htm)) 6) A new way to keep cancer‑fighting T cells from “burning out” - What’s new: Tumors exploit a molecular handshake between thrombospondin‑1 and CD47 to push T cells into exhaustion. Blocking that interaction (with a peptide called TAX2) kept T cells active in mice and boosted checkpoint therapy. - Why it matters: Pairing this with today’s immunotherapies could help more patients’ immune systems stay in the fight longer. - Read more: Weill Cornell summary + Nature Immunology paper. [ScienceDaily](https://www.sciencedaily.com/releases/2025/11/251120002828.htm) ([sciencedaily.com](https://www.sciencedaily.com/releases/2025/11/251120002828.htm)) Want this fun, scannable science mix each morning? Say: Daily science at 9am ET.